Literature DB >> 1160953

Chronic autoimmune neutropenia due to anti-NA2 antibody.

P Lalezari, A F Jiang, L Yegen, M Santorineou.   

Abstract

In exploring the immunologic causes of chronic neutropenia, we identified a persistent neutrophil-specific antibody with NA2 specificity in the blood of a nontransfused two-year-old girl with severe neutropenia. No such antibody was detected in the maternal blood. The antibody was first studied and identified when the patient was 11 months old, but she had had clinical manifestations since the age of one month. After a trial of steroid therapy, a marked but temporary reduction in the antibody titer occurred, accompanied by the rise of the neutrophils to normal level. Neutropenia reoccurred, however, when the antibody titer began to rise, despite continuation of steroid therapy. This transient response allowed the patient's neutrophils to become available and identified as NA2-positive. Although the cause of this disorder remains obscure, the data presented indicate that the anti-NA2 autoantibody is responsible for the neutropenia observed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1160953     DOI: 10.1056/NEJM197510092931504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  14 in total

1.  Autoimmune neutropenia of infancy.

Authors:  E G Lyall; G F Lucas; O B Eden
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  Severe autoimmune neutropenia associated with acute autoimmune hepatitis.

Authors:  Ahmad M Wehbe; Birgir Johannsson; Thomas J Raife; Michelle Bleile; Adam Bell; Brian R Curtis; Thorvardur R Halfdanarson
Journal:  Int J Hematol       Date:  2010-04-02       Impact factor: 2.490

Review 3.  The role of complement in immune clearance of blood cells.

Authors:  U E Nydegger; M D Kazatchkine
Journal:  Springer Semin Immunopathol       Date:  1983

4.  Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity.

Authors:  H F Pross; J Pater; I Dwosh; A Giles; L A Gallinger; P Rubin; W E Corbett; P Galbraith; M G Baines
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

5.  Immunological and haematological changes during high-dose immunoglobulin therapy in an infant with autoimmune neutropenia.

Authors:  H Ikeda; T Ozawa; H Takahashi; M Eguchi; T Furukawa; A Okuyama; K Saito; S Furusawa
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

6.  Autoimmune neutropenia: clinical and laboratory studies in 143 patients.

Authors:  J Bux; K Kissel; K Nowak; U Spengel; C Mueller-Eckhardt
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

7.  Activation of human complement by immunoglobulin G antigranulocyte antibody.

Authors:  P K Rustagi; M S Currie; G L Logue
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Auto-immune neutropenia in an infant.

Authors:  D S Thompson; P Stableforth; B Darlow; D M Brazier
Journal:  Postgrad Med J       Date:  1978-04       Impact factor: 2.401

9.  Cell mediated autoimmune granulocytopenia in a case of Felty's syndrome.

Authors:  S Slavin; M H Liang
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

10.  Characterization of polymorphic forms of Fc receptor III on human neutrophils.

Authors:  P A Ory; I M Goldstein; E E Kwoh; S B Clarkson
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.